Safe Practices for Medication Administration

Due 10-11-23 @10am

Euthanasia


Euthanasia & Physician Assisted Suicide (PAS)

After studying the course materials located on 

Module 8: Lecture Materials & Resources
 page, answer the following:

1. Euthanasia

· Medical / Generic definition

· Bioethical definition.

2. Describe pain and suffering within context of faith

3. Physician Assisted Suicide / Death ( PAS / PAD)

· Definition

· Is it ethical?

· Should we have the right to end our lives? Why yes or why not?

4. Better alternatives to PAS; compare and contrast each:

· Hospice

· Palliative care / Terminal sedation

5. Case studies. Brief summary of:

· Hemlock Society

· Jacob Kevorkian

· Britanny Maynard

Case 15

See attached report.

DUE TOMORROW 10/28/2023….PLEASE FOLLOW ALL INSTRUCTIONS AND USE THE TEMPLATE.

DIAGNOSIS: TENSION HEADACHE

32 YEAR-OLD FEMALE

AFRICAN AMERICAN

2 KIDS DELIVERED VIA C-SECTION

MEDICAL HISTORY: GASTRITIS, ANEMIA

VACCINES: HPV, COVID, 

PLEASE USE THE TEMPLATE AS A REFERENCE GUIDE TO ANSWERING EACH SECTION. PLEASE DELETE ALL REFERENCE INFORMATION ON THE TEMPLATE. 

AKI

 

Acute Kidney Injury (AKI) is highly prevalent in ICU settings and requires significant consideration.  AKI is rarely attributed to a single factor, and most critically ill patients who develop AKI have coexisting conditions.

Many forms of AKI are preventable and patients at risk should be evaluated early according to clinical condition and biomarkers.  Discuss AKI prevention and pharmacological treatment strategies.  Include specific recommendations for preventing or treating drug-induced AKI. 

Instructions:

Post your discussion to the Moodle Discussion Forum.  Initial post must be made by Day #3.  Word limit 500 words.  Reply to at least two other student posts with a reflection of their response.  Please make sure to provide citations and references (in APA, 7th ed. format) for your work.  

impacts of foundational neuroscience on the prescription of pharmacotherapeutics.

 

Explore the potential impacts of foundational neuroscience on the prescription of pharmacotherapeutics.

1.Analyze the agonist-to-antagonist spectrum of action of psychopharmacologic agents

2.Compare the actions of g couple proteins to ion gated channels

3.Analyze the role of epigenetics in pharmacologic action

4.Analyze the impact of foundational neuroscience on the prescription of medications

References x 3 

Consider a population health topic that rises to the presidential agenda level.

 Consider a population health topic that rises to the presidential agenda level. Which social determinant most affects this health issue? How did two recent presidents handle the problem? What would you do differently? 

NURSING nursing

Medication Errors

Nursing 9-4

 Develop an intervention (your capstone project), as a solution to the patient, family, or population problem you’ve defined.  

Replies week 8 MSN 5300

  Replies two peers with 200 words each one 

1.Sensitivity and specificity are measures of the accuracy of a screening test that we use to identify the presence or absence of a particular condition in an individual.

Sensitivity measures the proportion of true positives that are correctly identified by a screening test. In other words, it tells us the percentage of people who have the condition and are correctly identified by the screening test as having it.

Specificity measures the proportion of true negatives that are correctly identified by a screening test. That is, it tells us the percentage of people who do not suffer from the condition and who the screening test correctly identifies as not suffering.

Both sensitivity and specificity are important in determining the accuracy of a screening test, as they inform us about how effective the test is in correctly identifying both positive and negative cases. Ideally, we want a screening test that has high sensitivity and specificity, so that we can accurately identify the presence or absence of the condition being tested.

There are several factors that can affect sensitivity and specificity:

The threshold or cutoff value used to define a positive screening result. The lower the threshold, the more sensitivity increases but specificity decreases, while a higher threshold increases specificity but decreases sensitivity.

Also important is the prevalence of the condition in the population tested. In a population with high prevalence, the positive predictive value of the test may be higher, while in a population with low prevalence, false positive results may be more common.

Characteristics of the population being tested, such as age, sex, and comorbidities, which may influence the accuracy of the test.

It is important to note that sensitivity and specificity are not absolute measures of a test’s accuracy, but rather represent a balance between correctly identifying true positives and true negatives. Therefore, the decision to use a particular screening test should be based on a thorough evaluation of its performance characteristics and its suitability for the population being screened.

Considering the aforementioned aspects of sensitivity and specificity, we will be able to accurately address research studies, achieving better results.

2. Building evidence-based practice requires difficult assessment of diagnostic tests and measures. Sensitivity and specificity are vital parameters in identifying the validity of this important study. Sensitivity measures the ability of a test to properly identify individuals with a specific condition, while specificity gauges the ability to correctly identify individuals without the condition. Understanding these metrics is a fundamental advance study for healthcare and research settings for accurate disease identification and treatment planning. Sensitivity, also known as the true positive rate, measures the proportion of actual positives correctly identified by the test. High sensitivity ensures that individuals with the condition are unlikely to be missed, reducing the chances of false negatives. For instance, in cancer screening, a highly sensitive test detects can even detect early-stage of the cancers, leading to timely interventions and improved outcomes and like this be able to act. Sensitivity is crucial when early detection significantly influences patient prognosis, allowing for prompt medical intervention. On the other hand, specificity, or by other definition the true negative rate, reflects the proportion of individuals without the condition who are correctly identified by the test. High specificity minimizes false positives, confirming that healthy individuals are not unnecessarily subjected to further, potentially invasive, testing or treatments. For example, in HIV testing, high specificity is vital to prevent unnecessary emotional distress and healthcare costs resulting from false-positive results. Specificity is particularly important when a positive test result can lead to significant consequences, such as starting potent treatments or imposing lifestyle changes. There is often a difference between sensitivity and specificity. Increasing sensitivity may decrease specificity and vice versa, leading to a balance dilemma. Reaching to an optimal equilibrium is essential; too much focus on sensitivity might lead to overdiagnosis and overtreatment, while too much specificity might result in missed diagnoses. Applying the right balance will help individuals and it will and varies based on the medical condition, available treatments, and potential consequences of false results. 

     In summary, sensitivity and specificity are fundamental components in the screening aspects, tests playing a crucial role in evidence-based practice. Understanding and optimizing these parameters are imperative for clinicians and researchers, ensuring that diagnostic tests are trustworthy, leading to improved patient outcomes. By appreciating the balance between sensitivity and specificity, healthcare professionals can make informed choices, enhancing the quality of care and advancing evidence-based medicine.